NO20011282D0 - Nytt influensavirusvaksinepreparat - Google Patents
Nytt influensavirusvaksinepreparatInfo
- Publication number
- NO20011282D0 NO20011282D0 NO20011282A NO20011282A NO20011282D0 NO 20011282 D0 NO20011282 D0 NO 20011282D0 NO 20011282 A NO20011282 A NO 20011282A NO 20011282 A NO20011282 A NO 20011282A NO 20011282 D0 NO20011282 D0 NO 20011282D0
- Authority
- NO
- Norway
- Prior art keywords
- influenza virus
- virus vaccine
- vaccine preparation
- new influenza
- mug
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/145—Orthomyxoviridae, e.g. influenza virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5252—Virus inactivated (killed)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55505—Inorganic adjuvants
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/16011—Orthomyxoviridae
- C12N2760/16111—Influenzavirus A, i.e. influenza A virus
- C12N2760/16134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/16011—Orthomyxoviridae
- C12N2760/16211—Influenzavirus B, i.e. influenza B virus
- C12N2760/16234—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AT0155598A AT408615B (de) | 1998-09-15 | 1998-09-15 | Neue influenzavirus-impfstoffzusammensetzung |
PCT/AT1999/000223 WO2000015251A2 (de) | 1998-09-15 | 1999-09-14 | Influenzavirus-impfstoffzusammensetzung |
Publications (2)
Publication Number | Publication Date |
---|---|
NO20011282D0 true NO20011282D0 (no) | 2001-03-14 |
NO20011282L NO20011282L (no) | 2001-05-14 |
Family
ID=3515932
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20011282A NO20011282L (no) | 1998-09-15 | 2001-03-14 | Nytt influensavirusvaksinepreparat |
Country Status (12)
Country | Link |
---|---|
US (1) | US6372223B1 (no) |
EP (1) | EP1113816B1 (no) |
JP (1) | JP2003523310A (no) |
AT (2) | AT408615B (no) |
AU (1) | AU763210B2 (no) |
DE (1) | DE59913046D1 (no) |
DK (1) | DK1113816T3 (no) |
ES (1) | ES2257072T3 (no) |
HK (1) | HK1038507A1 (no) |
HU (1) | HUP0103908A3 (no) |
NO (1) | NO20011282L (no) |
WO (1) | WO2000015251A2 (no) |
Families Citing this family (62)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AT407958B (de) | 1999-02-11 | 2001-07-25 | Immuno Ag | Inaktivierte influenza-virus-vakzine zur nasalen oder oralen applikation |
GB9923176D0 (en) * | 1999-09-30 | 1999-12-01 | Smithkline Beecham Biolog | Novel composition |
AU2356002A (en) * | 2000-09-25 | 2002-04-02 | Polymun Scient Immunbio Forsch | Live vaccine and method of manufacture |
JP2004531578A (ja) * | 2001-06-29 | 2004-10-14 | ベクトン・ディキンソン・アンド・カンパニー | ワクチンおよび遺伝子治療剤のマイクロカニューレによる皮内送達 |
IL145926A0 (en) * | 2001-10-15 | 2002-07-25 | Mor Research Applic Ltd | Peptide epitopes of mimotopes useful in immunomodulation |
KR100597699B1 (ko) * | 2003-01-30 | 2006-07-07 | 학교법인 포항공과대학교 | 면역원성이 증강된 dna 백신 조성물 |
US7588774B2 (en) * | 2003-05-12 | 2009-09-15 | Becton, Dickinson And Company | Molecules enhancing dermal delivery of influenza vaccines |
US20050123550A1 (en) * | 2003-05-12 | 2005-06-09 | Laurent Philippe E. | Molecules enhancing dermal delivery of influenza vaccines |
DE602004028736D1 (de) | 2003-06-20 | 2010-09-30 | Microbix Biosystems Inc | Verbesserungen bei der virusproduktion |
US20050281832A1 (en) * | 2003-12-05 | 2005-12-22 | Campbell Robert L | Methods of enhancing immune response in the intradermal compartment and compounds useful thereof |
CA2559371C (en) | 2004-03-09 | 2014-07-08 | Chiron Corporation | Influenza virus vaccines |
KR20060135931A (ko) * | 2004-04-01 | 2006-12-29 | 알자 코포레이션 | 인플루엔자 백신의 경피전달 장치 및 방법 |
US8221969B2 (en) * | 2004-04-19 | 2012-07-17 | Sanyo Chemical Industries, Ltd. | Method of producing virus |
ATE489965T1 (de) | 2004-09-09 | 2010-12-15 | Novartis Vaccines & Diagnostic | Verminderung von potentiellen iatrogenen risiken in verbindung mit influenza impfstoffen |
JP2008519042A (ja) | 2004-11-03 | 2008-06-05 | ノバルティス ヴァクシンズ アンド ダイアグノスティクス, インコーポレイテッド | インフルエンザワクチン接種 |
US20060121055A1 (en) * | 2004-12-06 | 2006-06-08 | Becton, Dickinson And Company, Inc. | Compositions with enhanced immunogenicity |
CA2601022C (en) * | 2005-03-23 | 2023-03-07 | Glaxosmithkline Biologicals S.A. | Use of an influenza virus an oil-in-water emulsion adjuvant to induce cd4 t-cell and/or improved b-memory cell response |
US11707520B2 (en) | 2005-11-03 | 2023-07-25 | Seqirus UK Limited | Adjuvanted vaccines with non-virion antigens prepared from influenza viruses grown in cell culture |
GB0522601D0 (en) * | 2005-11-04 | 2005-12-14 | Chiron Srl | Adjuvanted influenza vaccines and kits |
EA014190B1 (ru) * | 2005-11-04 | 2010-10-29 | Новартис Вэксинс Энд Диагностикс Срл | Вакцины против гриппа, адсорбированные на алюминиевых адъювантах, для немедленного приёма |
NZ568210A (en) | 2005-11-04 | 2012-12-21 | Novartis Vaccines & Diagnostic | Emulsions with free aqueous-phase surfactant as adjuvants for split influenza vaccines |
EP2377551A3 (en) * | 2005-11-04 | 2013-04-24 | Novartis Vaccines and Diagnostics S.r.l. | Adjuvanted influenza vaccines including cytokine-inducing agents |
PT2368572T (pt) | 2005-11-04 | 2020-06-16 | Seqirus Uk Ltd | Vacinas com adjuvante dotadas de antigénios não-virião preparados a partir de vírus da gripe cultivado em cultura celular |
US8697087B2 (en) * | 2005-11-04 | 2014-04-15 | Novartis Ag | Influenza vaccines including combinations of particulate adjuvants and immunopotentiators |
ES2619160T7 (es) | 2006-01-27 | 2020-07-29 | Seqirus Uk Ltd | Vacunas contra la gripe que contienen hemaglutinina y proteínas de la matriz |
JP2009534303A (ja) | 2006-03-24 | 2009-09-24 | ノバルティス ヴァクシンズ アンド ダイアグノスティクス ゲーエムベーハー アンド カンパニー カーゲー | 冷蔵しないインフルエンザワクチンの保存 |
DK2054431T3 (da) | 2006-06-09 | 2012-01-02 | Novartis Ag | Konformere af bakterielle adhæsiner |
WO2008009309A1 (en) | 2006-07-17 | 2008-01-24 | Glaxosmithkline Biologicals S.A. | Influenza vaccine |
CA3016948A1 (en) | 2006-09-11 | 2008-03-20 | Seqirus UK Limited | Making influenza virus vaccines without using eggs |
EA200900784A1 (ru) | 2006-12-06 | 2009-12-30 | Новартис Аг | Вакцины, включающие антиген из четырех штаммов вируса гриппа |
WO2008095677A1 (en) * | 2007-02-07 | 2008-08-14 | Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. | Recombinant antigens of human cytomegalovirus (hcmv) |
AR066405A1 (es) | 2007-04-20 | 2009-08-19 | Glaxosmithkline Biolog Sa | Vacuna |
PL2185191T3 (pl) | 2007-06-27 | 2013-02-28 | Novartis Ag | Szczepionki przeciwko grypie o małej zawartości dodatków |
GB0818453D0 (en) | 2008-10-08 | 2008-11-12 | Novartis Ag | Fermentation processes for cultivating streptococci and purification processes for obtaining cps therefrom |
CA2710480A1 (en) * | 2007-12-24 | 2009-07-02 | Novartis Ag | Assays for adsorbed influenza vaccines |
CA2733356C (en) * | 2008-08-01 | 2016-06-07 | Gamma Vaccines Pty Limited | Influenza vaccines |
EP2396032B1 (en) | 2009-02-10 | 2016-09-28 | Seqirus UK Limited | Influenza vaccines with reduced amounts of squalene |
US9907746B2 (en) | 2009-07-06 | 2018-03-06 | Variation Biotechnologies, Inc. | Methods for preparing vesicles and formulations produced therefrom |
MX2012000372A (es) | 2009-07-06 | 2012-02-28 | Variation Biotechnologies Inc | Metodos para preparar vesiculas y formulaciones producidas a partir de las mismas. |
JP5872472B2 (ja) | 2009-10-09 | 2016-03-01 | シービオ・リミティッド | シャペロニン10変異体 |
US9107875B2 (en) | 2009-11-18 | 2015-08-18 | Auburn University | Low antigen-dose immunization for maximizing T-helper cell 1 (Th1) immunity against a pathogen |
US9610248B2 (en) | 2010-07-06 | 2017-04-04 | Variation Biotechnologies, Inc. | Compositions and methods for treating influenza |
CA2812135A1 (en) | 2010-09-07 | 2012-03-15 | Novartis Ag | Generic assays for detection of mammalian reovirus |
FR2966044B1 (fr) | 2010-10-18 | 2012-11-02 | Sanofi Pasteur | Procede de conditionnement d'un vaccin contenant un adjuvant d'aluminium |
AU2012205315B2 (en) | 2011-01-13 | 2017-05-04 | Variation Biotechnologies, Inc. | Methods for preparing vesicles and formulations produced therefrom |
CN103501811B (zh) | 2011-01-13 | 2016-03-30 | 变异生物技术公司 | 用于治疗病毒感染的组合物和方法 |
AU2012211043B2 (en) | 2011-01-27 | 2017-04-06 | Gamma Vaccines Pty Limited | Combination vaccines |
WO2013072768A2 (en) | 2011-11-18 | 2013-05-23 | Variation Biotechnologies, Inc. | Synthetic derivatives of mpl and uses thereof |
AU2013208693B2 (en) | 2012-01-12 | 2017-12-07 | Variation Biotechnologies Inc. | Compositions and methods for treating viral infections |
US20150079077A1 (en) | 2012-01-27 | 2015-03-19 | Variation Biotechnologies, Inc. | Methods and compositions for therapeutic agents |
NZ714625A (en) | 2012-03-23 | 2017-02-24 | Pitney Pharmaceuticals Pty Ltd | Kinase inhibitors for the treatment of cancer |
CA2875683A1 (en) | 2012-06-05 | 2013-12-12 | The Australian National University | Vaccination with interleukin-4 antagonists |
EP2880014B1 (en) | 2012-08-06 | 2017-05-17 | Pitney Pharmaceuticals Pty Limited | Compounds for the treatment of mtor pathway related diseases |
GB201218195D0 (en) | 2012-10-10 | 2012-11-21 | Istituto Zooprofilattico Sperimentale Delle Venezie | Composition |
KR102255753B1 (ko) | 2012-12-17 | 2021-05-26 | 뉴사우스 이노베이션즈 피티와이 리미티드 | 뮤신 관련 질환의 치료 |
EP3446708A1 (en) | 2012-12-24 | 2019-02-27 | Cell Ideas Pty Ltd. | Vaccines for the treatment of cancer and compositions for enhancing vaccine efficacy |
US10364277B2 (en) | 2013-07-01 | 2019-07-30 | Newsouth Innovations Pty Limited | Diagnosis and treatment of autoimmune diseases |
US20150166255A1 (en) * | 2013-12-12 | 2015-06-18 | ASCLEMED USA, INC. dba EnovaChem Manufacturing | Vitamin b-12 injection kit |
US10293044B2 (en) | 2014-04-18 | 2019-05-21 | Auburn University | Particulate formulations for improving feed conversion rate in a subject |
ES2782428T3 (es) | 2014-04-18 | 2020-09-15 | Univ Auburn | Formulaciones vacunales de partículas para la inducción de inmunidad innata y adaptativa |
CN116603058A (zh) | 2015-03-26 | 2023-08-18 | Gpn疫苗有限公司 | 链球菌疫苗 |
WO2018176103A1 (en) | 2017-03-30 | 2018-10-04 | The University Of Queensland | "chimeric molecules and uses thereof" |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SK280702B6 (sk) * | 1992-05-23 | 2000-06-12 | Smithkline Beecham Biologicals S. A. | Kombinovaný očkovací prostriedok obsahujúci povrch |
DK0791055T3 (da) * | 1994-11-10 | 2012-04-16 | Baxter Healthcare Sa | Fremgangsmåde til fremstilling af biologiske produkter i proteinfri kultur |
FR2754715B1 (fr) * | 1996-10-18 | 1998-11-13 | Seppic Sa | Adjuvant, notamment sous forme d'une emulsion contenant un cation metallique trivalent et composition vaccinale le comprenant |
US5795582A (en) | 1996-02-07 | 1998-08-18 | Novavax, Inc. | Adjuvant properties of poly (amidoamine) dendrimers |
-
1998
- 1998-09-15 AT AT0155598A patent/AT408615B/de not_active IP Right Cessation
-
1999
- 1999-09-14 US US09/787,322 patent/US6372223B1/en not_active Expired - Fee Related
- 1999-09-14 DE DE59913046T patent/DE59913046D1/de not_active Expired - Lifetime
- 1999-09-14 HU HU0103908A patent/HUP0103908A3/hu unknown
- 1999-09-14 AU AU57200/99A patent/AU763210B2/en not_active Ceased
- 1999-09-14 WO PCT/AT1999/000223 patent/WO2000015251A2/de active IP Right Grant
- 1999-09-14 EP EP99944154A patent/EP1113816B1/de not_active Revoked
- 1999-09-14 DK DK99944154T patent/DK1113816T3/da active
- 1999-09-14 JP JP2000569835A patent/JP2003523310A/ja active Pending
- 1999-09-14 AT AT99944154T patent/ATE315404T1/de active
- 1999-09-14 ES ES99944154T patent/ES2257072T3/es not_active Expired - Lifetime
-
2001
- 2001-03-14 NO NO20011282A patent/NO20011282L/no not_active Application Discontinuation
-
2002
- 2002-01-03 HK HK02100022A patent/HK1038507A1/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
NO20011282L (no) | 2001-05-14 |
DK1113816T3 (da) | 2006-04-03 |
AT408615B (de) | 2002-01-25 |
US6372223B1 (en) | 2002-04-16 |
HUP0103908A2 (hu) | 2002-02-28 |
ES2257072T3 (es) | 2006-07-16 |
HUP0103908A3 (en) | 2003-10-28 |
EP1113816A2 (de) | 2001-07-11 |
JP2003523310A (ja) | 2003-08-05 |
WO2000015251A2 (de) | 2000-03-23 |
ATA155598A (de) | 2001-06-15 |
AU763210B2 (en) | 2003-07-17 |
WO2000015251A3 (de) | 2000-08-24 |
ATE315404T1 (de) | 2006-02-15 |
EP1113816B1 (de) | 2006-01-11 |
DE59913046D1 (de) | 2006-04-06 |
HK1038507A1 (en) | 2002-03-22 |
AU5720099A (en) | 2000-04-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20011282D0 (no) | Nytt influensavirusvaksinepreparat | |
EP1618889B8 (en) | Influenza Vaccine | |
UA85536C2 (en) | Viral antigens | |
ATE298580T1 (de) | Eigenschaften von poly(amidoamine) dendrimeren als adjuvantien | |
UY26555A1 (es) | Composición farmacéutica para modulación inmunológica y preparación de vacunas | |
CY1106635T1 (el) | Ανοσοενισχυτικο που περιεχει ν - φορμυλο μεθειονυλο-πεπτιδια για εμβολια | |
CY1107457T1 (el) | Εμβoλιο κατa του hpv | |
UA42089C2 (uk) | Протигрипозна вакцина на основі поверхневого антигену, спосіб її виробництва | |
ATE315405T1 (de) | Cpg-zusammensetzungen, saponin-adjuvantien und verfahren zu deren verwendung | |
AU2002355677A1 (en) | Antigenic polypeptides | |
NO20001768D0 (no) | Viruskapsomervaksine, fremgangsmåte til fremstilling samt anvendelse derav | |
BR9906927A (pt) | Proteìnas de neisseria meningitidis | |
MY133780A (en) | Vaccine composition | |
WO2004062597A3 (en) | Compositions, methods and kits for enhancing the immunogenicity of a bacterial vaccine vector | |
GB9818133D0 (en) | Vaccine | |
CO5050367A1 (es) | Nueva composicion | |
DK1401492T3 (da) | LTB4 som vaccineadjuvans | |
ATE374622T1 (de) | Genetische impstoffe mit adjuvans | |
WO2002077648A3 (en) | Pathogenic and commensal vaccine antigens | |
IT1318400B1 (it) | Markers di massa molecolare per westner blot. | |
NZ316110A (en) | vaccine containing an antigen from H. Influenzae and an antigen from influenza virus | |
UA67250A (en) | Strain bovinae herpesvirus-1 "moldavian" for the preparation of vaccines and diagnosticums | |
EA199900583A2 (ru) | Композиция на основе метопролола и способы ее получения |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |